Latest news

11/04/2019

Targeted approach to therapy for rare type of bone cancer

Press release by NCT Heidelberg. Chordomas are rare bone tumors for which only few options of treatment exist. Scientists and doctors from the National Center for Tumor Diseases (NCT), the German…

04/04/2019

UA Ruhr Researchers Jointly Develop Basis for Targeted Cancer Therapy

Press release of the TU Dortmund. From basic research to application – the way to drug discovery is long. Scientists from TU Dortmund University, the Medical Faculty of the University of…

03/04/2019

Our medicine is research

The aim of SYNERGIE, the new magazine published jointly by the German Centers of Health Research (DZG,) is to present modern medical research and provide a brief digest of the latest research…

25/03/2019

Cancer research must have a social impact – A new strategy concept for Europe

Curing cancer is one of five key focus areas of Horizon Europe, the new European framework program for research and innovation. This was decided by the Competetiveness Council of the European Union in…

21/03/2019

The evolution of brain tumors

Scientists from the German Cancer Research Center and German Cancer Consortium (DKTK) found in a recent study that only three different genetic alterations drive the early development of malignant…

21/02/2019

Colon cancer: Different Wnt signaling pathways lead colon cells astray

Signaling molecules in the Wnt family are some of the most essential messengers for continuous regeneration of our stressed colon mucosa. At the same time, “too much” Wnt is a frequent trigger for…

31/01/2019

Psychiatric drug as a new treatment for leukemia

A new kind of leukemia treatment using an antidepressant could offer a new option to patients who are resistant to current therapies. German Cancer Consortium (DKTK) scientists working at the…

28/01/2019

New biomarker to monitor skin cancer therapies

Press release of UDE/University Hospital Essen Merkel cell carcinoma is a rare but highly aggressive form of skin cancer that is triggered by a virus or by UV light. A biomarker that can monitor the…

31/12/2018

EMBO Young Investigator Award for Hind Medyouf

Dr. Hind Medyouf, a DKTK faculty member at the Frankfurt site and a group leader at the Institute for Tumor Biology and Experimental Therapy and the Frankfurt Cancer Institute, has been awarded the…

20/12/2018

DKTK says thank you and Merry Christmas!

We look forward to further projects with our physicians, scientists, partners and supporters to fight cancer!

19/12/2018

Nature publication reports first-in-human trial of a novel actively personalized therapeutic vaccine for brain cancer

Press Release by Glioma Actively Personalized Vaccine Consortium (GAPVAC) The prospect of an actively personalized approach to the treatment of glioblastoma has moved a step closer with the recent…

12/12/2018

High distinction for stem cell researcher Andreas Trumpp

This year's State Research Prize of Baden-Württemberg awarded for outstanding achievements in applied research goes to Andreas Trumpp from the German Cancer Research Center (DKFZ), German Cancer…

10/12/2018

The sleeping beauty among brain tumors

Press release by KiTZ Scientists from the Hopp Children's Tumor Center Heidelberg (KiTZ), together with two other teams from the German Cancer Association (DKTK) and researchers from the UK, have…

05/12/2018

NCT/DKTK-MASTER: Cancer genome analysis nearing clinical application

Press Release of the NCT Heidelberg Scientists today are able to observe tumor cells in increasing detail and thus gain a better understanding of how cancer cells differ from healthy ones. Doctors…

29/11/2018

Strengthening the digital future of cancer research

The German Research Foundation (DFG) has approved the CompCancer doctoral program on computer methods for personalized cancer treatment. The aim is for young scientists enrolled on the program to…

21/10/2018

Taking a look at the genes of brain tumors helps in making the right therapy decision

Press release of KiTZ Researchers from the „Hopp-Children’s Cancer Center“ (KiTZ) together with colleagues from the US, showed substantial molecular diversity behind seemingly similar embryonal brain…

13/09/2018

Cell environment influences type of liver tumor

Press release of the University Hospital Tübingen Liver cancer is the second leading cause of cancer death worldwide. Two different forms of primary liver cancer cover the majority of cases: About…

12/09/2018

Detecting and treating prostate cancer

Press release of the Helmholtz Association Four scientists from Heidelberg have developed a more reliable method to diagnose prostate cancer and even fight it in a targeted manner. They have now…

11/09/2018

New approach uncovers tumor promoting signaling pathway in common children’s brain tumor

Press release of KiTZ A study conducted by researchers of the "Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ)" together with colleagues from the Institute Curie (Orsay, France) and the…

04/09/2018

microRNAs predict recurrence risk of head and neck tumors

Press release of the LMU A new method predicts the course of HPV-negative head and neck cancer after radiation chemotherapy. According to a recent article in the journal ‘Clinical Cancer Research’,…